Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SomatoKine (Iplex) in Myotonic Dystrophy Type 1
NCT00233519Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2005
- Primary completion
- May 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of mecasermin in myotonic dystrophy type 1 (DM1), sponsored by University of Rochester. Started Nov 2005; status: completed.
02
Drugs
mecasermin
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on NCT00233519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233519.